INS and breast cancer: Epidemiological and clinical studies have shown that T2DM is a risk factor for BC and is consequently associated with poor prognosis.43 Wairagu et al.44 investigated the effects of oestradiol on MCF-7 BC cells primed with and without insulin chronically.